banner add

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

from NYT > Health https://ift.tt/pUmI5sh
via IFTTT

No comments

U.S.A.I.D. Memos Detail Human Costs of Cuts to Foreign Aid

The world is likely to see millions more malaria infections and 200,000 cases of paralytic polio each year, according to an agency whistle-b...

Theme images by PLAINVIEW. Powered by Blogger.